Targeting PD-L1 With Chimeric Antigen Receptor Modified NK Cells Induces Tumor Control and Reduction of PD-L1 High Immune Populations by nantkweststg | Jan 28, 2021
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations by nantkweststg | Jan 28, 2021
Engineered killer immune cells target tumours and their immunosuppressive allies by nantkweststg | Jan 28, 2020
Recent Comments